ArticleFrontiers in oncology2024

Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab:

Veronica Murianni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.